From: Interactions between meat intake and genetic variation in relation to colorectal cancer
Gene | rs-numberd | N cases | N sub-cohort | IRR/OR (95 % CI)a | P bint | Commentsc | First author | Year | References | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Cooking carcinogens and mutagens | |||||||||||
NAT1 | Slow | 120 | 123 | 4 | Chen | 1998 | Chen et al. (1998) | ||||
NAT*10 allele | Rapid | 92 | 98 | 0.19 | 4 | Chen et al. (1998) | |||||
NAT2 | Slow | 131 | 125 | 4 | Chen et al. (1998) | ||||||
Rapid | 81 | 96 | 0.56 | 4 | Chen et al. (1998) | ||||||
NAT2 | Slow | 107 | 267 | 5 | Chan | 2005 | Chan et al. (2005) | ||||
Rapid | 76 | 476 | 0.07 | 5 | Chan et al. (2005) | ||||||
NAT1 | Slow | 0.99 (0.94–1.04) | 2, 3, 6 | Sorensen | 2008 | Sorensen et al. (2008) | |||||
Fast | 0.98 (0.90–1.05) | >0.40 | 2, 3, 6 | Sorensen et al. (2008) | |||||||
NAT2 | Slow | 1.00 (0.95–1.06) | 2, 3, 6 | Sorensen et al. (2008) | |||||||
Fast | 0.96 (0.90–1.03) | >0.40 | 2, 3, 6 | Sorensen et al. (2008) | |||||||
NAT1 | No*10 | 362 | 527 | 7 | Nothlings | 2009 | Nothlings et al. (2009) | ||||
*10 | 482 | 818 | 0.77 | 7 | Nothlings et al. (2009) | ||||||
NAT2 | Slow/med | 750 | 1149 | 7 | Nothlings et al. (2009) | ||||||
Rapid | 242 | 344 | 0.44 | 7 | Nothlings et al. (2009) | ||||||
NAT1 | No*10 | 362 | 527 | 8 | Nothlings et al. (2009) | ||||||
*10 | 482 | 818 | 0.93 | 8 | Nothlings et al. (2009) | ||||||
NAT2 | Slow/med | 750 | 1,149 | 8 | Nothlings et al. (2009) | ||||||
Rapid | 242 | 344 | 0.13 | 8 | Nothlings et al. (2009) | ||||||
AHR | rs2066853 | 364 | 394 | 0.07 | 12 | Gilsing | 2012 | Gilsing et al. (2012) | |||
UGT1A | rs6714486 | 364 | 394 | 0.06 | 12 | Gilsing et al. (2012) | |||||
rs17868299 | 364 | 394 | 0.05 | 12 | Gilsing et al. (2012) | ||||||
UGT1A | rs2011404 | 364 | 394 | 0.08 | 12 | Gilsing et al. (2012) | |||||
CYP2E1 | rs915908 | 364 | 394 | 0.05 | 12 | Gilsing et al. (2012) | |||||
UGT1A | rs6717546 | 364 | 394 | 0.04 | 12 | Gilsing et al. (2012) | |||||
UGT1A | rs12466997 | 364 | 394 | 0.08 | 12 | Gilsing et al. (2012) | |||||
Arachidonic acid pathway | |||||||||||
PTGS2 (COX-2) | rs689566 | A-1195G | AA–AG | 900 | 1,686 | 1.02 (0.98–1.05) | 1, 2, 3 | Andersen | 2013 | Andersen et al. (2013b) | |
GG | 47 | 61 | 1.06 (0.87–1.29) | 0.54 | 1, 2, 3 | Andersen et al. (2013b) | |||||
rs20417 | G-765C | GG | 701 | 1,256 | 0.99 (0.95–1.03) | 1, 2, 3 | Andersen et al. (2013b) | ||||
GC–CC | 235 | 478 | 1.08 (1.01–1.15) | 0.006 | 1, 2, 3 | Andersen et al. (2013b) | |||||
rs5275 | T8473C | TT | 430 | 720 | 1.04 (0.99–1.09) | 1, 2, 3 | Andersen et al. (2013b) | ||||
TC–CC | 501 | 1,018 | 1.01 (0.96–1.05) | 0.29 | 1, 2, 3 | Andersen et al. (2013b) | |||||
Transport proteins | |||||||||||
ABCB1 (MDR1) | rs1045642 | 3435 | CC | 73 | 118 | 1.08 (1.00–1.16) | 1, 2, 3 | Andersen | 2009 | Andersen et al. (2009) | |
CT–TT | 286 | 647 | 1.00 (0.95–1.06) | 0.02 | 1, 2, 3 | Andersen et al. (2009) | |||||
rs3789243 | Intron 3 | GG | 81 | 224 | 0.95 (0.89–1.02) | 1, 2, 3 | Andersen et al. (2009) | ||||
GA–AA | 278 | 541 | 1.03 (0.98–1.09) | 0.01 | 1, 2, 3 | Andersen et al. (2009) | |||||
ABCG2 (BCRP) | rs2231142 | C421A | CC | 296 | 592 | 1.02 (0.97–1.08) | 1, 2, 3 | Andersen et al. (2009) | |||
CA–AA | 63 | 173 | 0.99 (0.91–1.08) | 0.40 | 1, 2, 3 | Andersen et al. (2009) | |||||
ABCC2 (MRP2) | rs717620 | C-24T | CC | 260 | 508 | 1.02 (0.97–1.07) | 1, 2, 3 | Andersen | 2012 | Andersen et al. (2012b) | |
CT–TT | 129 | 280 | 1.03 (0.95–1.12) | 0.72 | 1, 2, 3 | Andersen et al. (2012b) | |||||
rs2273697 | G1249A | GG | 238 | 480 | 1.05 (0.99–1.11) | 1, 2, 3 | Andersen et al. (2012b) | ||||
AG–AA | 151 | 308 | 0.98 (0.91–1.05) | 0.10 | 1, 2, 3 | Andersen et al. (2012b) | |||||
rs3740066 | C3972T | CC | 143 | 301 | 1.01 (0.96–1.08) | 1, 2, 3 | Andersen et al. (2012b) | ||||
CT–TT | 246 | 487 | 1.03 (0.97–1.10) | 0.69 | 1, 2, 3 | Andersen et al. (2012b) | |||||
Cytokines | |||||||||||
IL10 | rs1800872 | C-592A | CC | 238 | 470 | 1.02 (0.97–1.07) | 1, 2, 3, 9 | Andersen | 2012 | Andersen et al. (2012b) | |
AC–AA | 140 | 305 | 1.02 (0.95–1.11) | 0.92 | 1, 2, 3, 9 | Andersen et al. (2012b) | |||||
rs3024505 | CC | 268 | 553 | 1.02 (0.96–1.08) | 1, 2, 3, 9 | Andersen et al. (2012b) | |||||
CT–TT | 110 | 222 | 1.03 (0.96–1.10) | 0.78 | 1, 2, 3, 9 | Andersen et al. (2012b) | |||||
IL10 | rs1800872 | C-592A | CC | 596 | 1072 | 1.02 (0.98–1.06) | 1, 2, 3 | Andersen | 2013 | Andersen et al. (2013b) | |
AC–AA | 353 | 676 | 1.00 (0.95–1.06) | 0.46 | 1, 2, 3 | Andersen et al. (2013b) | |||||
rs3024505 | CC | 648 | 1,200 | 1.00 (0.96–1.04) | 1, 2, 3 | Andersen et al. (2013b) | |||||
CT–TT | 297 | 565 | 1.06 (1.00–1.11) | 0.04 | 1, 2, 3 | Andersen et al. (2013b) | |||||
IL1B | rs4848306 | C-3737T | CC | 336 | 560 | 1.01 (0.96–1.07) | 1, 2, 3 | Andersen et al. (2013b) | |||
CT–TT | 605 | 1,186 | 1.02 (0.98–1.06) | 0.65 | 1, 2, 3 | Andersen et al. (2013b) | |||||
rs1143623 | G-1464C | GG | 454 | 925 | 1.02 (0.97–1.06) | 1, 2, 3 | Andersen et al. (2013b) | ||||
GC–CC | 492 | 824 | 1.02 (0.97–1.07) | 0.94 | 1, 2, 3 | Andersen et al. (2013b) | |||||
rs1143627 | T-31C | TT | 389 | 773 | 1.00 (0.96–1.05) | 1, 2, 3 | Andersen et al. (2013b) | ||||
TC–CC | 557 | 983 | 1.03 (0.98–1.07) | 0.40 | 1, 2, 3 | Andersen et al. (2013b) | |||||
Transcription factors | |||||||||||
NFKB1 | rs28362491 | −94 ins/del | II | 122 | 307 | 0.96 (0.90–1.04) | 1, 2, 3 | Andersen | 2010 | Andersen et al. (2010) | |
ID–DD | 261 | 456 | 1.03 (0.97–1.08) | 0.03 | 1, 2, 3 | Andersen et al. (2010) | |||||
NR1I2 (PXR) | rs1523127 | A-24381C | AA | 131 | 261 | 1.04 (0.97–1.12) | 1, 2, 3 | Andersen et al. (2010) | |||
AC–CC | 252 | 502 | 1.01 (0.95–1.06) | 0.20 | 1, 2, 3 | Andersen et al. (2010) | |||||
rs2276707 | C8055T | CC | 237 | 448 | 1.02 (0.96–1.08) | 1, 2, 3 | Andersen et al. (2010) | ||||
CT–TT | 146 | 315 | 1.01 (0.95–1.08) | 0.74 | 1, 2, 3 | Andersen et al. (2010) | |||||
rs6785049 | A7635G | AA | 137 | 264 | 1.01 (0.95–1.07) | 1, 2, 3 | Andersen et al. (2010) | ||||
AG–GG | 246 | 499 | 1.02 (0.96–1.08) | 0.60 | 1, 2, 3 | Andersen et al. (2010) | |||||
NR1H2 (LXR) | rs1405655 | CC | 40 | 76 | 1.01 (0.93–1.10) | 1, 2, 3 | Andersen et al. (2010) | ||||
CT–TT | 343 | 687 | 1.02 (0.96–1.07) | 0.94 | 1, 2, 3 | Andersen et al. (2010) | |||||
rs2695121 | TT | 117 | 227 | 1.03 (0.96–1.11) | 1, 2, 3 | Andersen et al. (2010) | |||||
CT–CC | 266 | 536 | 1.01 (0.96–1.07) | 0.43 | 1, 2, 3 | Andersen et al. (2010) | |||||
Heme oxygenase | Andersen et al. (2011a) | ||||||||||
HMOX1 (HO-1) | rs2071746 | A-413T | AA | 118 | 260 | 1.00 (0.93–1.08) | 1, 2, 3 | Andersen | 2011 | ||
AT–TT | 265 | 503 | 1.02 (0.97–1.08) | 0.55 | 1, 2, 3 | ||||||
DNA repair | |||||||||||
MSH3 | rs184967 | R940Q | RR | 127 | 8, 10 | Berndt | 2007 | Berndt et al. (2007) | |||
RQ–QQ | 65 | 0.08 | 8, 10 | Berndt et al. (2007) | |||||||
MSH3 | rs26279 | T1036A | TT | 85 | 8, 10 | Berndt et al. (2007) | |||||
TA–AA | 102 | 0.002 | 8, 10 | Berndt et al. (2007) | |||||||
MSH6 | rs1042821 | G39E | GG | 118 | 8, 10 | Berndt et al. (2007) | |||||
GE–EE | 54 | 0.29 | 8, 10 | Berndt et al. (2007) | |||||||
MLH1 | rs1799977 | I219V | II | 84 | 8, 10 | Berndt et al. (2007) | |||||
IV–VV | 101 | 0.40 | 8, 10 | Berndt et al. (2007) | |||||||
XPC | Rs2228001d | Lys939Gln | AA | 141 | 307 | 1.17 (0.71–1.92) | 7, 11 | Hansen | 2007 | Hansen et al. (2007) | |
AC | 204 | 392 | 1.11 (0.70–1.75) | 7, 11 | Hansen et al. (2007) | ||||||
CC | 50 | 98 | 3.70 (1.70–8.04) | 0.01 | 7, 11 | Hansen et al. (2007) | |||||
XPA | A23G | GG | 176 | 339 | 1.30 (0.78–2.17) | 7, 11 | Hansen et al. (2007) | ||||
AG | 187 | 359 | 1.41 (0.87–2.26) | 7, 11 | Hansen et al. (2007) | ||||||
AA | 31 | 90 | 0.76 (0.34–1.66) | 0.37 | 7, 11 | Hansen et al. (2007) | |||||
ERCC2 (XPD) | Rs1799793d | Asp312Asn | GG | 159 | 333 | 1.25 (0.69–2.26) | 7, 11 | Hansen et al. (2007) | |||
AG | 191 | 354 | 1.25 (0.83–1.87) | 7, 11 | Hansen et al. (2007) | ||||||
AA | 46 | 108 | 1.22 (0.61–2.45) | 1.00 | 7, 11 | Hansen et al. (2007) | |||||
XPC | Rs2228001d | Lys939Gln | AA | 141 | 307 | 0.63 (0.23–1.69) | 8, 11 | Hansen et al. (2007) | |||
AC | 204 | 392 | 0.94 (0.41–2.15) | 8, 11 | Hansen et al. (2007) | ||||||
CC | 50 | 98 | 3.78 (0.64–22.29) | 0.20 | 8, 11 | Hansen et al. (2007) | |||||
XPA | A23G | GG | 176 | 339 | 0.58 (0.23–1.48) | 8, 11 | Hansen et al. (2007) | ||||
AG | 187 | 359 | 1.87 (0.73–4.83) | 8, 11 | Hansen et al. (2007) | ||||||
AA | 31 | 90 | 0.31 (0.06–1.64) | 0.06 | 8, 11 | Hansen et al. (2007) | |||||
ERCC2 (XPD) | Rs1799793d | Asp312Asn | GG | 159 | 333 | 1.07 (0.38–3.03) | 8, 11 | Hansen et al. (2007) | |||
AG | 191 | 354 | 0.75 (0.33–1.68) | 8, 11 | Hansen et al. (2007) | ||||||
AA | 46 | 108 | 1.93 (0.43–8.63) | 0.49 | 8, 11 | Hansen et al. (2007) |